Literature DB >> 11240985

Occult lymph node metastases in supraglottic cancers of the larynx.

E D Esposito1, S Motta, B Cassiano, G Motta.   

Abstract

Occult cervical lymph node metastases may often be associated with cancers of the supraglottic larynx. The aims of this investigation were: (1) to determine the incidence of occult lymph node metastases in patients with cancer of the larynx; (2) to assess whether the presence of such metastases was related to the extent of the primary tumor (T) and its grading (G); and (3) to discuss which therapeutic approach should be followed in treating clinically occult lymph node metastases. Our investigation included 97 patients who underwent supraglottic horizontal laryngectomy and elective cervical lymph node dissection. The incidence of occult lymph node metastases in the series considered was 27%. Based on the preoperative staging of the tumor, 14% of the cases had metastatically involved lymph nodes in the T1 tumors, 21% in the T2 tumors, 35% in the T3, and 75% in the T4. In the statistical analysis, a significant difference was shown to exist when T1 + T2 and T3 + T4 (P = 0.04) were compared. In terms of grading, occult metastases were found in 16% of the G1 tumors, 27% of the G2, and 42% of the G3. The statistical analysis demonstrated a significant difference between G1 and G3. In brief, the incidence of occult metastases was higher for the less differentiated tumors and for the ones with a higher T value; the effects of both factors are combined thereby increasing the rate of occult metastases (P = 0.05).

Entities:  

Mesh:

Year:  2001        PMID: 11240985     DOI: 10.1067/mhn.2001.113146

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  6 in total

1.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

2.  Clinicopathological Factors of Cervical Nodal Metastasis and the Concept of Selective Lateral Neck Dissection in the Surgical Management of Carcinoma Larynx and Hypopharynx and Its Outcome.

Authors:  Elizabeth Mathew Iype; Sreekanth S Kumar; Bipin T Varghese; Jaya C Jose
Journal:  Indian J Surg Oncol       Date:  2017-05-09

3.  Assessment of Occult Nodal Micrometastases to the Clinically Negative Contralateral Neck in Locally Advanced Supraglottic Squamous Cell Carcinoma.

Authors:  Ahmad Mohamed Eltelety; Mohamed Aly Abou-Zeid; Mena Esmat Abdelmalek; Ahmed Amin Nassar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-08-17

4.  Patterns of Cervical Lymph Node Metastasis in Locally Advanced Supraglottic Squamous Cell Carcinoma: Implications for Neck CTV Delineation.

Authors:  Yi Xu; Ye Zhang; Zhengang Xu; Shaoyan Liu; Guozhen Xu; Li Gao; Jingwei Luo; Xiaodong Huang; Kai Wang; Yuan Qu; Shiping Zhang; Qingfeng Liu; Runye Wu; Xuesong Chen; Junlin Yi
Journal:  Front Oncol       Date:  2020-08-27       Impact factor: 6.244

5.  Rate of Occult Cervical Lymph Node Involvement in Supraglottic Squamous Cell Carcinoma.

Authors:  Maziar Motiee Langroudi; Behrooz Amirzargar; Amin Amali; Mohammad Sadeghi; Mehrdad Jafar; Mohammad Reza Hoseini; Fatemeh Tavakolnejad
Journal:  Iran J Otorhinolaryngol       Date:  2017-05

6.  CO2 Transoral Microsurgery for Supraglottic Squamous Cell Carcinoma.

Authors:  Filippo Carta; Cinzia Mariani; Giovanni B Sambiagio; Natalia Chuchueva; Elisa Lecis; Clara Gerosa; Roberto Puxeddu
Journal:  Front Oncol       Date:  2018-09-04       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.